Very disappointed with the company's performance and apparent lack of complete disclosure. I should have thought that when a CEO makes a statement to the effect that something will happen by a certain date and it does not happen that an explanation is called for. By my reckoning GMV should have CFDA approval for it's device, a fully operational factory and significant sales revenues following on from all those contracts.
The thing is that others are also playing in this space and if we aren't up, up and away very soon we will become bystanders looking on at one of the most promising developments in the health space in a generation.
GMV Price at posting:
20.0¢ Sentiment: Hold Disclosure: Held